Bellerophon Therapeutics Inc (BLPH) USD0.01
Sell:$0.05Buy:$0.05
$0.00 (4.73%)
- This stock can be held in a
Stocks and Shares ISASell:$0.05
Buy:$0.05
Change:$0.00 (4.73%)
$0.00 (4.73%)Prices delayed by at least 15 minutes
Sell:$0.05
Buy:$0.05
Change:$0.00 (4.73%)
$0.00 (4.73%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 13 October 2023 | PUISSANCE CAPITAL MANAGEMENT LPFamily Holding | Sell Regular sell transaction (market) | 1,076,841 | $0.10 | $111,776.10 | 0 |
| 7 June 2023 | PUISSANCE LIFE SCIENCE OPPORTUNITIES FUND VIVenture Capital | Sell Regular sell transaction (market) | 134,421 | $0.83 | $111,569.43 | 1,076,841 |
| 18 May 2023 | PUISSANCE LIFE SCIENCE OPPORTUNITIES FUND VIVenture Capital | Sell Regular sell transaction (market) | 560,000 | $9.46 | $5,297,600.00 | 1,211,262 |
| 18 May 2023 | Bobae KimVice President | Sell Regular sell transaction (market) | 9,455 | $10.00 | $94,550.00 | 1,723 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 May 2023 | PUISSANCE LIFE SCIENCE OPPORTUNITIES FUND VIVenture Capital | Sell Regular sell transaction (market) | 560,000 | $9.46 | $5,297,600.00 | 1,211,262 |
| 13 October 2023 | PUISSANCE CAPITAL MANAGEMENT LPFamily Holding | Sell Regular sell transaction (market) | 1,076,841 | $0.10 | $111,776.10 | 0 |
| 7 June 2023 | PUISSANCE LIFE SCIENCE OPPORTUNITIES FUND VIVenture Capital | Sell Regular sell transaction (market) | 134,421 | $0.83 | $111,569.43 | 1,076,841 |
| 18 May 2023 | Bobae KimVice President | Sell Regular sell transaction (market) | 9,455 | $10.00 | $94,550.00 | 1,723 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.